| Price | 81.50p on 28-11-2025 at 18:10:05 |
|---|---|
| Change | 1.10p 1.37% |
| Buy | 82.00p |
| Sell | 81.00p |
| Last Trade: | Unknown 119,295.00 at 81.40p |
| Day's Volume: | 1,774,837 |
| Last Close: | 81.40p |
| Open: | 80.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 81.40p - 81.40p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £353.00m |
| VWAP: | 80.86718p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 119,295 | 81.40p | OTC Trade |
17:08:16 - 28-Nov-25 |
| Sell* | 37,945 | 81.37p | Ordinary |
16:36:26 - 28-Nov-25 |
| Sell* | 35,000 | 81.37p | Ordinary |
16:35:37 - 28-Nov-25 |
| Sell* | 50,066 | 81.40p | Uncrossing Trade |
16:35:14 - 28-Nov-25 |
| Sell* | 1,232 | 81.3541p | Ordinary |
16:29:37 - 28-Nov-25 |
| Sell* | 1,240 | 81.35p | Ordinary |
16:29:02 - 28-Nov-25 |
| Buy* | 5,000 | 82.00p | Ordinary |
16:28:55 - 28-Nov-25 |
| Buy* | 5,000 | 81.90p | Ordinary |
16:27:51 - 28-Nov-25 |
| Buy* | 5,000 | 81.75p | Ordinary |
16:27:00 - 28-Nov-25 |
| Buy* | 5,000 | 81.75p | Ordinary |
16:26:28 - 28-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
